Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
Rafael Barrera, MD, Director of the Surgical Intensive Care Unit at Long Island Jewish (LIJ) Medical Center in New York, discusses the problem of malnutrition in hospitalized patients.…
Rafael Barrera, MD, Director of the Surgical Intensive Care Unit at Long Island Jewish (LIJ) Medical Center in New York, discusses how to ensure that central line catheters…
Mal de Debarquement Syndrome (MdDS) usually develops after exposure to motion. Commonly, it occurs after a cruise or plane ride. Its symptoms include the perception of swaying —…
NEW YORK (Reuters Health) – Despite being recommended by the American Heart Association, there is no evidence that immediate beta-blockade in patients with ST-segment elevation myocardial infarction (STEMI)…
NEW YORK (Reuters Health) – When spontaneous circulation is restored after cardiac arrest, patients with hyperoxia have higher rates of in-hospital mortality than those with hypoxia or normal…
NEW YORK (Reuters Health) – Hospitalized cirrhotics are at increased risk for venous thromboembolism (VTE) up until age 45 but not afterward, a new study suggests. Patients hospitalized…
Andrew Charles, MD, Professor, Director of Headache Research and Treatment Program, UCLA David Geffen School of Medicine, discusses migraine and what to tell your patients. This is a…
Gary Small, MD, Director, UCLA Center on Aging, UCLA, discusses the testing of new compounds like supplements and anti-amyloid compounds to help protect healthy brains before Alzheimer’s disease…
Richard J Shemin, MD, Chief of Cardiothoracic Surgery, UCLA David Geffen School of Medicine, discusses the future of cardiothoracic surgery, which may see such innovations as the development…
NEW YORK (Reuters Health) – Combined bivalirudin (Angiomax) and vascular closure devices are better to staunch bleeding after percutaneous coronary intervention (PCI) than either strategy alone, according to…
